Top Medical News

Dietary Vitamin C and E Associated with Lower Risk of Parkinson Disease

January 18, 2021

By Victoria Johnson

Further associations with lowered risk of Parkinson were observed with BMI and coffee intake.

Causal Link Between Smoking and Subarachnoid Hemorrhage

January 18, 2021

By Marco Meglio

People who were genetically predisposed to smoking behaviors were at a 63% greater risk for subarachnoid hemorrhage.

Inconsistencies Identified Across EEG Neurology Education Tactics

January 18, 2021

By Marco Meglio

The findings showed that 64% of EEG education programs did not utilize objective measures to assess EEG milestones.

This Week on NeurologyLive — January 18, 2020

January 18, 2021

By NeurologyLive Staff

Here's what is coming soon to NeurologyLive.

NMOSD Early Age of Onset Predicts Severe Residual Vision Loss

January 17, 2021

By Victoria Johnson

Patients with an early age of onset (AO) were also more likely to receive less effective first-line oral therapy than those with later AOs.

Featured

Coverage of the AES 2020 Virtual Meeting

The latest news and research presented in epilepsy and related disorders.

Episode 26: Digital Approaches to Comprehensive Care in MS

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Leigh Charvet, PhD.

NeuroVoices: Fabio Nascimento, MD, on Improving EEG Education in Residency Programs

The clinical fellow at Massachusetts General Hospital detailed his research on neurology resident EEG education, and the increased need for more consistency throughout programs.

Latest Videos

Expert Perspectives: Advances in the Management of Acute Migraine

Updates in the Management of Relapsing Multiple Sclerosis

Treating Epilepsy: Key Takeaways From AES 2020

Richard B. Lipton, MD: Achieving Simultaneous Acute and Preventive Migraine Treatment

William Rosenfeld, MD: Reducing Concomitant ASM Dosages for Focal Seizures

Raymond Sanchez, MD: Phase 2 Trial Data of Tavapadon in Parkinson Disease

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

Brian Wainger, MD, PhD: Momentum Within the ALS Treatment Landscape

Evaluation of Spinal Muscular Atrophy in the Era of Telehealth

Leo Petrossian, PhD, MBA: Accelerating Optimization of Epilepsy Management

Richard B. Lipton, MD: CGRP Receptor-Targeting in the Prevention of Migraine

Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval System

Brian Wainger, MD, PhD: Future Studies Evaluating Motor Neuron Excitability in ALS

Most Recent

Biogen, Apple to Initiate Study to Develop Cognitive Health Digital Biomarkers

January 16, 2021

Article

Maha Radhakrishnan, MD, the Group SVP and chief medical officer at Biogen, discussed the collaborative study between Biogen and Apple that’s expected to kick off later this year.

Helius Technologies Submits FDA Response in Pursuit of PoNS De Novo Classification

January 15, 2021

Article

The FDA previously declined to approve de novo classification in April 2019.

NeurologyLive Friday 5 — January 15, 2021

January 15, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 15, 2021.

Consumer Sleep Tracking Devices Perform Equally or Better Than Actigraphy

January 15, 2021

Article

No devices performed better than polysomnography, but the researchers believe they warrant further testing.

Episode 27: Short, Sudden, Strange, Similar Spells

January 15, 2021

Podcast

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Jacqueline French, MD.

Cenobamate’s Efficacy in Seizure Freedom and Decreasing Concomitant Medication Use

January 14, 2021

Article

William Rosenfeld, MD, discusses the decreases his team observed in concomitant medication use with cenobamate in patients with focal seizures.

ABC/2 Method Shows Strong Accuracy in Measuring Infarct Volume

January 14, 2021

Article

The ability of the ABC/2 method to correctly identify patients with an infarct volume below a pre-defined cut-point proved to be very high for various cut-points.

EDSS Less Accurate Than Other Outcome Measures for Secondary Progressive MS

January 14, 2021

Article

The EDSS inaccurately reported improvement rates while paralleling disability progression rates.

P-Tau181 Associated With Longitudinal Neurodegeneration in Alzheimer Disease

January 14, 2021

Article

The findings suggest and confirm previous studies that suggested plasma p-tau181 may be used as a measure to monitor Alzheimer disease progression in clinical practice and treatment trials.

MIND Diet Effective in Delaying Parkinson Onset in Women

January 13, 2021

Article

Men were observed to derive benefit from a Greek Mediterranean diet and women were found to generally adhere more closely to diet interventions than men.

New AASM Guidelines Make Strong Recommendation for Behavioral Therapy in Chronic Insomnia

January 13, 2021

Article

The new American Academy of Sleep Medicine guidelines are the first to use the GRADE system of evaluating behavioral insomnia therapies.

Experimental DMD Gene Therapy Phase 3 Trial Launched

January 13, 2021

Article

The Pfizer candidate PF-06939926 has also received fast track, orphan drug, and rare pediatric disease designations from the FDA.

NeuroVoices: Fabio Nascimento, MD, on Improving EEG Education in Residency Programs

January 13, 2021

Article

The clinical fellow at Massachusetts General Hospital detailed his research on neurology resident EEG education, and the increased need for more consistency throughout programs.

Pediatric Version of Disposable EEG NeuroCap Available Early 2021

January 12, 2021

Article

Brain Scientific’s disposable EEG cap can be applied by any clinical staff member within 5 minutes.

Low Amyloid-β Deposition, Dopaminergic Activity Characterize MCI With Lewy Body Dementia

January 12, 2021

Article

Researchers found amyloid-β positron emission tomography imaging and dopamine transporter imaging to be useful in characterizing phenotypes of the neurodegenerative conditions.

Vutrisiran Meets Primary End Points in hATTR Amyloidosis With Polyneuropathy

January 12, 2021

Article

The hATTR amyloidosis treatment demonstrated an encouraging safety and tolerability profile, with a new drug application submission expected to come this year.

Biogen Announces First Patient Dosed in Phase 4 Trial of Nusinersen in SMA

January 12, 2021

Article

The phase 4 study will use total score on the Hammersmith Infant Neurological Examination Section 2 motor milestones as the primary end point over a 2-year period.

SB623 Mesenchymal Stem Cell Implantation Efficacious and Well-Tolerated in TBI

January 11, 2021

Article

There was no statistically significant difference between treatment-related adverse events in the SB623 stem cell and control groups.

Donanemab Shows Slowing of Decline in Alzheimer Phase 2 TRAILBLAZER-ALZ Study

January 11, 2021

Article

The follow-up TRAILBLAZER-EXT and broader population TRAILBLAZER-ALZ 2 studies are currently ongoing.

Epileptic Peripartum and Postpartum Seizure Frequency Unchanged by Pregnancy

January 11, 2021

Article

The percentage of women who had ≥1 change in an antiepileptic drug dose or an overall dose increase during pregnancy and a decrease in dose during the postpartum period was higher among pregnant women than controls.